Form 4: Quest Diagnostics Director Acquires Shares Through Dividend Reinvestment

Director Vicky B. Gregg acquired 68 shares of Quest Diagnostics through a dividend reinvestment plan at a price of $164.422 per share.

Summary

• On April 21, 2025, Vicky B. Gregg, a director of Quest Diagnostics Inc., acquired 68 shares of common stock.
• The shares were acquired through a dividend reinvestment plan.
• The price per share was $164.422.
• Following the transaction, Gregg directly owns 16,935 shares of Quest Diagnostics.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction (dividend reinvestment) by a director, indicating confidence but not a major event.

Positives

• The director's participation in the dividend reinvestment plan signals confidence in the company's future.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Directors purchasing shares through dividend reinvestment plans is a common practice and generally viewed positively by the market, as it aligns the interests of management with those of shareholders.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders as it signals confidence from a company director.

Key Dates

Keywords

Quest Diagnostics, Director, Vicky B. Gregg, Dividend Reinvestment Plan, Share Acquisition, Form 4, DGX